A detailed history of Sapient Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sapient Capital LLC holds 60,130 shares of JNJ stock, worth $9.32 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
60,130
Previous 61,727 2.59%
Holding current value
$9.32 Million
Previous $9.02 Million 8.0%
% of portfolio
0.2%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$145.48 - $167.38 $232,331 - $267,305
-1,597 Reduced 2.59%
60,130 $9.74 Million
Q2 2024

Jul 15, 2024

SELL
$144.38 - $157.78 $219,890 - $240,298
-1,523 Reduced 2.41%
61,727 $9.02 Million
Q1 2024

Apr 22, 2024

BUY
$155.22 - $162.74 $989,372 - $1.04 Million
6,374 Added 11.21%
63,250 $10 Billion
Q4 2023

Feb 06, 2024

BUY
$145.6 - $158.88 $601,473 - $656,333
4,131 Added 7.83%
56,876 $8.91 Billion
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $7.68 Million - $8.38 Million
52,745 New
52,745 $8.27 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.